GB0905127D0 - Novel prodrugs - Google Patents

Novel prodrugs

Info

Publication number
GB0905127D0
GB0905127D0 GBGB0905127.7A GB0905127A GB0905127D0 GB 0905127 D0 GB0905127 D0 GB 0905127D0 GB 0905127 A GB0905127 A GB 0905127A GB 0905127 D0 GB0905127 D0 GB 0905127D0
Authority
GB
United Kingdom
Prior art keywords
novel prodrugs
prodrugs
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0905127.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharminox Ltd
Original Assignee
Pharminox Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharminox Ltd filed Critical Pharminox Ltd
Priority to GBGB0905127.7A priority Critical patent/GB0905127D0/en
Publication of GB0905127D0 publication Critical patent/GB0905127D0/en
Priority to PCT/GB2010/050490 priority patent/WO2010109230A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GBGB0905127.7A 2009-03-25 2009-03-25 Novel prodrugs Ceased GB0905127D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0905127.7A GB0905127D0 (en) 2009-03-25 2009-03-25 Novel prodrugs
PCT/GB2010/050490 WO2010109230A1 (en) 2009-03-25 2010-03-24 Novel prodrugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0905127.7A GB0905127D0 (en) 2009-03-25 2009-03-25 Novel prodrugs

Publications (1)

Publication Number Publication Date
GB0905127D0 true GB0905127D0 (en) 2009-05-06

Family

ID=40640140

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0905127.7A Ceased GB0905127D0 (en) 2009-03-25 2009-03-25 Novel prodrugs

Country Status (2)

Country Link
GB (1) GB0905127D0 (en)
WO (1) WO2010109230A1 (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
US6184225B1 (en) 1996-02-13 2001-02-06 Zeneca Limited Quinazoline derivatives as VEGF inhibitors
DE69709319T2 (en) 1996-03-05 2002-08-14 Astrazeneca Ab 4-ANILINOQUINAZOLINE DERIVATIVES
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
ES2351699T3 (en) 1999-02-10 2011-02-09 Astrazeneca Ab DERIVATIVES OF QUINAZOLINA AS INHIBITORS OF THE ANGIOGENESIS AND INTERMEDIATES OF THE SAME.
JP2003535078A (en) 2000-05-31 2003-11-25 アストラゼネカ アクチボラグ Indole derivatives with vascular damage activity
UA73993C2 (en) 2000-06-06 2005-10-17 Астразенека Аб Quinazoline derivatives for the treatment of tumours and a pharmaceutical composition
EP1301498A1 (en) 2000-07-07 2003-04-16 Angiogene Pharmaceuticals Limited Colchinol derivatives as angiogenesis inhibitors
BR0112224A (en) 2000-07-07 2003-06-10 Angiogene Pharm Ltd Compound, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt, solvate or prodrug thereof, and process for preparing a compound
US7307099B2 (en) 2002-12-20 2007-12-11 Cancer Research Technology Limited 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents

Also Published As

Publication number Publication date
WO2010109230A1 (en) 2010-09-30

Similar Documents

Publication Publication Date Title
HRP20140223T1 (en) Dolutegravir prodrugs
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
EP2462514A4 (en) Greenbooks
EP2515891A4 (en) 3-keto-n-propargyl-1-aminoindan
ZA201109437B (en) Novel azabicyclohexanes
ZA201105535B (en) Novel tricyanoborates
IL213673A0 (en) Spiroindolinone derivative prodrugs
EP2519921A4 (en) Call-tracking
DK2464943T3 (en) Systemintegration
GB0900568D0 (en) Poymerisation
GB0900319D0 (en) Hydrocharger
EP2510125A4 (en) Hyperprimers
GB0905127D0 (en) Novel prodrugs
AU4240P (en) Tuckerbox xTriticosecale
AU4924P (en) Bonscablue Scaevola aemula
AU4925P (en) Bonscawi Scaevola aemula
AU4926P (en) Bonscalib Scaevola aemula
GB0904353D0 (en) Novel thiazolopyrimidines
GB0916131D0 (en) Fitted sheets-01
EG26256A (en) Oxyga
GB0900167D0 (en) B b
AP2009000321S (en) Doropak
AU329913S (en) Cupcan
AU324442S (en) Keylight

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)